| scholarly article | Q13442814 |
| P50 | author | Ross S Francis | Q81309848 |
| P2093 | author name string | Gang Feng | |
| Kathryn J Wood | |||
| Andrew Bushell | |||
| Thanyalak Tha-In | |||
| Ian S Lyons | |||
| P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice | Q29622850 | ||
| Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. | Q34269503 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| CD3-specific antibodies: a portal to the treatment of autoimmunity | Q34654024 | ||
| "Infectious" transplantation tolerance. | Q34726892 | ||
| Plasticity of CD4+ T cell lineage differentiation. | Q34982725 | ||
| The complementary roles of deletion and regulation in transplantation tolerance | Q35058547 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens | Q36228356 | ||
| Allograft rejection mediated by memory T cells is resistant to regulation | Q36288969 | ||
| Malignancy after transplantation | Q36298305 | ||
| Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action | Q36350238 | ||
| Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus | Q36402576 | ||
| Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen | Q36403106 | ||
| Developmental regulation of Foxp3 expression during ontogeny. | Q36403564 | ||
| Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
| Beyond histology: novel tools to diagnose allograft dysfunction | Q36910361 | ||
| Infection in solid-organ transplant recipients | Q37038203 | ||
| Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo | Q37312884 | ||
| Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease | Q38306073 | ||
| Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection | Q41712619 | ||
| Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells | Q42114183 | ||
| Why T cells of thymic versus extrathymic origin are functionally different | Q42644575 | ||
| Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients | Q44482864 | ||
| Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. | Q46057969 | ||
| Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. | Q46116579 | ||
| Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells | Q46602684 | ||
| CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. | Q46763767 | ||
| Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression | Q46825318 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy | Q47302070 | ||
| Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants | Q47644499 | ||
| Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. | Q51769095 | ||
| Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. | Q51966551 | ||
| Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. | Q51995747 | ||
| Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 | ||
| Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
| CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
| Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner | Q56906395 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness | Q71157351 | ||
| Improved graft survival after renal transplantation in the United States, 1988 to 1996 | Q73502580 | ||
| Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process | Q75224536 | ||
| Regulatory T cells mediate maternal tolerance to the fetus | Q75394803 | ||
| GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function | Q80054509 | ||
| TLR engagement prevents transplantation tolerance | Q80256970 | ||
| CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion | Q81111400 | ||
| Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection | Q93747372 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 726-738 | |
| P577 | publication date | 2011-01-17 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells | |
| P478 | volume | 41 |
| Q54216691 | A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants. |
| Q42099442 | A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen |
| Q34043187 | Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression |
| Q48004570 | Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells |
| Q41050325 | Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model |
| Q47098903 | Calcium-mediated shaping of naive CD4 T-cell phenotype and function. |
| Q41526519 | Changes in Reactivity In Vitro of CD4+CD25+ and CD4+CD25- T Cell Subsets in Transplant Tolerance |
| Q52682313 | Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies. |
| Q30430008 | Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation |
| Q88025066 | Cytokines affecting CD4+T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+T regulatory cells |
| Q38515353 | Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance. |
| Q37065735 | Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity? |
| Q42817955 | Donor-specific regulatory T cells generated on donor B cells are superior to CD4+CD25high cells in controlling alloimmune responses in humanized mice |
| Q55433915 | Equal Expansion of Endogenous Transplant-Specific Regulatory T Cell and Recruitment Into the Allograft During Rejection and Tolerance. |
| Q37019142 | Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure |
| Q35875359 | Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. |
| Q37864694 | Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells |
| Q26751474 | Immunological aspects of liver cell transplantation |
| Q90185646 | Impact of infection on transplantation tolerance |
| Q61802512 | Kidney Transplant Outcome Is Associated with Regulatory T Cell Population and Gene Expression Early after Transplantation |
| Q33614049 | Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry |
| Q38445344 | Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance |
| Q37662989 | Old game, new players: Linking classical theories to new trends in transplant immunology |
| Q36866534 | Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection |
| Q38191610 | Regulatory T cells as immunotherapy |
| Q27011620 | Regulatory T cells in transplantation |
| Q38485004 | Regulatory T cells: first steps of clinical application in solid organ transplantation |
| Q27025869 | Regulatory T-cell therapy in transplantation: moving to the clinic |
| Q38013048 | Regulatory immune cells in transplantation |
| Q90955751 | Strategies to achieve immune tolerance in allogeneic solid organ transplantation |
| Q37967572 | Suppression assays with human T regulatory cells: a technical guide. |
| Q26823613 | T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells |
| Q57146361 | T Follicular Regulatory Cells and Antibody Responses in Transplantation |
| Q37965366 | TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. |
| Q82372020 | The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation |
| Q50914665 | The high-risk corneal regraft model: a justification for tissue matching in humans. |
| Q91559975 | The pursuit of transplantation tolerance: new mechanistic insights |
| Q38039091 | Translating tolerogenic therapies to the clinic - where do we stand? |
| Q59400011 | Transplantation tolerance |
| Q26829817 | Transplantation tolerance and its outcome during infections and inflammation |
| Q26744447 | mTOR inhibitors effects on regulatory T cells and on dendritic cells |
Search more.